GO:0000050 urea cycle: Nitrogen Detoxification Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000050 (urea cycle) is the biological process that converts toxic ammonia into urea via five enzymatic reactions, using ornithine as a carrier and regenerating it in each turn.
• The cycle is encoded by six core genes (CPS1, OTC, ASS1, ASL, ARG1, NAGS) plus mitochondrial transporters and accessory enzymes.
• Urea cycle dysregulation is a hallmark of inherited urea cycle disorders, and acquired alterations are increasingly recognized in cancer, Alzheimer's disease, and immune evasion.
• In cancer, urea cycle reprogramming supports pyrimidine synthesis, redox balance, and immune escape, making it a prospective therapeutic target.
• In Alzheimer's disease, an astrocytic urea cycle detoxifies amyloid-beta-derived ammonia but may impair memory, linking nitrogen metabolism to neurodegeneration.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of urea cycle genes in metabolism and disease.
Description
The urea cycle (GO:0000050) is the central metabolic pathway that detoxifies ammonia by converting it into urea, while also serving as the only route for endogenous arginine synthesis. This process is essential for nitrogen homeostasis in terrestrial vertebrates and is tightly regulated at transcriptional and post-translational levels. Beyond its classical role in liver, urea cycle enzymes are expressed in extrahepatic tissues and tumors, where they contribute to metabolic reprogramming and disease progression. Understanding the urea cycle is therefore critical for researchers in inherited metabolic disorders, cancer metabolism, immunology, and neuroscience. The pathway's complexity and its crosstalk with the tricarboxylic acid (TCA) cycle and oxidative metabolism make it a rich area for functional genomics and CRISPR-based interrogation.
urea cycle At A Glance
| GO ID | GO:0000050 |
|---|---|
| GO term | urea cycle |
| Ontology | biological_process |
| Synonym | ornithine cycle; urea biosynthesis; urea biosynthetic process |
| Major function | Detoxification of ammonia to urea and endogenous synthesis of arginine |
| Key enzymes | CPS1, OTC, ASS1, ASL, ARG1, NAGS |
| Subcellular location | Mitochondrial matrix and cytosol (enzymes distributed across compartments) |
| Pathway equation | NH3 + CO2 + aspartate + 3 ATP + 2 H2O = urea + fumarate + 2 ADP + 2 phosphate + AMP + diphosphate |
| Related diseases | Urea cycle disorders, hyperammonemia, cancer, Alzheimer's disease |
What Is GO:0000050?
According to the Gene Ontology, GO:0000050 (urea cycle) is defined as the sequence of reactions by which arginine is synthesized from ornithine, then cleaved to yield urea and regenerate ornithine. The overall balanced equation is NH3 + CO2 + aspartate + 3 ATP + 2 H2O = urea + fumarate + 2 ADP + 2 phosphate + AMP + diphosphate. This process encompasses five enzymatic steps: carbamoyl phosphate synthetase I (CPS1), ornithine transcarbamylase (OTC), argininosuccinate synthetase (ASS1), argininosuccinate lyase (ASL), and arginase (ARG1), with N-acetylglutamate synthase (NAGS) providing the essential cofactor N-acetylglutamate.
Why Is urea cycle Important in Cell Biology?
The urea cycle is indispensable for nitrogen disposal and arginine homeostasis, and its dysfunction leads to hyperammonemia, a life-threatening condition. Inborn errors of the cycle cause severe neurological damage if untreated, and newborn screening programs rely on detecting these defects. Moreover, recent studies have revealed that urea cycle enzymes are reprogrammed in cancer, where they support tumor growth and immune evasion, and in Alzheimer's disease, where astrocytic urea cycle activity may influence cognitive decline. Thus, the urea cycle sits at the intersection of inherited metabolism, oncology, and neuroscience, making it a high-priority research area.
• Prevents hyperammonemia by converting toxic ammonia to urea.
• Serves as the sole endogenous source of arginine, a precursor for nitric oxide, polyamines, and creatine.
• Mutations in urea cycle genes cause inherited urea cycle disorders with severe neurological consequences.
• Urea cycle dysregulation is a metabolic hallmark of many cancers and contributes to immune evasion.
• Astrocytic urea cycle activity detoxifies amyloid-beta-derived ammonia in Alzheimer's disease models.
• Links to the TCA cycle via fumarate and aspartate, influencing oxidative metabolism.
• Provides targets for therapeutic intervention in hyperammonemia and cancer.
• Enables functional genomics studies using CRISPR screens to identify metabolic vulnerabilities.
• Involved in nitrogen recycling and waste management across species.
• Serves as a model for studying compartmentalized metabolic pathways.
What Happens During urea cycle?
Carbamoyl Phosphate Synthesis
In simple terms: The cycle starts by combining ammonia and bicarbonate to make a reactive intermediate.
In the mitochondrial matrix, carbamoyl phosphate synthetase I (CPS1) catalyzes the ATP-dependent condensation of ammonia and bicarbonate to form carbamoyl phosphate. This step requires N-acetylglutamate (NAG) as an essential allosteric activator, which is synthesized by N-acetylglutamate synthase (NAGS). CPS1 is the rate-limiting enzyme of the urea cycle and is subject to regulation by NAG levels and hormonal signals.
Citrulline Formation
In simple terms: The reactive intermediate is combined with ornithine to form citrulline.
Ornithine transcarbamylase (OTC) transfers the carbamoyl group from carbamoyl phosphate to ornithine, yielding citrulline and releasing phosphate. OTC is a mitochondrial enzyme and its deficiency is the most common urea cycle disorder. Citrulline is then transported to the cytosol for subsequent steps.
Argininosuccinate Synthesis
In simple terms: Citrulline is joined with aspartate to build argininosuccinate.
In the cytosol, argininosuccinate synthetase (ASS1) catalyzes the ATP-dependent condensation of citrulline with aspartate to form argininosuccinate. This step incorporates the second nitrogen atom destined for urea and is a key regulatory node. ASS1 deficiency causes citrullinemia type I.
Arginine and Fumarate Release
In simple terms: Argininosuccinate is split into arginine and fumarate.
Argininosuccinate lyase (ASL) cleaves argininosuccinate into arginine and fumarate. Fumarate enters the TCA cycle, linking nitrogen disposal to energy metabolism. Arginine is then available for the final step or for other biosynthetic pathways.
Urea Production and Ornithine Regeneration
In simple terms: Arginine is broken down to release urea and regenerate ornithine.
Arginase (ARG1 in the cytosol) hydrolyzes arginine to urea and ornithine, completing the cycle. Ornithine re-enters mitochondria to initiate another round. Urea is excreted, while ornithine is recycled. This step is also a source of polyamines and proline.
Key Genes Involved in GO:0000050 urea cycle
The following genes encode the core enzymes and regulators of the urea cycle, each with distinct roles and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CPS1 | Catalyzes carbamoyl phosphate synthesis; rate-limiting enzyme | Target for hyperammonemia and cancer metabolism studies |
| OTC | Converts carbamoyl phosphate and ornithine to citrulline | Most commonly mutated in urea cycle disorders; model for X-linked inheritance |
| ASS1 | Synthesizes argininosuccinate from citrulline and aspartate | Frequently downregulated in cancers; linked to citrullinemia |
| ASL | Cleaves argininosuccinate to arginine and fumarate | Connects urea cycle to TCA cycle; deficiency causes argininosuccinic aciduria |
| ARG1 | Hydrolyzes arginine to urea and ornithine | Central to nitrogen disposal; target in cancer immunotherapy |
| ARG2 | Mitochondrial arginase; regulates TCA cycle and oxidative metabolism | Emerging role in hepatocyte metabolism and cancer |
| NAGS | Synthesizes N-acetylglutamate, essential CPS1 activator | Defects cause NAG synthase deficiency; target for pharmacological activation |
| SLC25A15 | Mitochondrial ornithine transporter | Mutations cause hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| SLC25A13 | Mitochondrial aspartate/glutamate carrier | Deficiency causes citrin deficiency and adult-onset type II citrullinemia |
| SLC7A1 | Cationic amino acid transporter for arginine uptake | Modulates arginine availability for urea cycle and nitric oxide synthesis |
| GLS | Glutaminase; provides ammonia for urea cycle | Links glutamine metabolism to ureagenesis in cancer and liver |
| GLUL | Glutamine synthetase; detoxifies ammonia in brain | Counterbalances urea cycle in astrocytes; relevant to Alzheimer's disease |
| OAT | Ornithine aminotransferase; degrades ornithine | Regulates ornithine levels; deficiency causes gyrate atrophy |
| PYCR1 | Pyrroline-5-carboxylate reductase; proline synthesis from ornithine | Connects urea cycle to proline metabolism in cancer |
| NOS1 | Neuronal nitric oxide synthase; consumes arginine | Competes with arginase for arginine in neurotransmission |
| NOS2 | Inducible nitric oxide synthase; consumes arginine | Links urea cycle to immune response and inflammation |
| CAD | Carbamoyl phosphate synthetase II for pyrimidine synthesis | Shares carbamoyl phosphate with urea cycle; target in cancer |
| OTC | Ornithine transcarbamylase (duplicate entry for emphasis) | Model for gene therapy and CRISPR correction |
How Is urea cycle Regulated?
The urea cycle is regulated at multiple levels. Acutely, CPS1 activity is controlled by N-acetylglutamate, whose synthesis by NAGS is stimulated by arginine and acetyl-CoA. Hormonally, glucagon and glucocorticoids induce urea cycle enzyme expression during fasting or high-protein diets, while insulin suppresses it. Long-term regulation involves transcriptional control of CPS1, OTC, ASS1, ASL, and ARG1 by transcription factors such as C/EBP and HNF4α. In cancer, urea cycle enzymes are reprogrammed by oncogenic signals and metabolic stress, often involving mTOR and MYC. In Alzheimer's disease, astrocytic urea cycle activity is induced by amyloid-beta-derived ammonia, implicating a stress-responsive pathway.
urea cycle and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| OTC | Ornithine transcarbamylase deficiency; hyperammonemia | Otc knockout mouse; patient-derived iPSCs for CRISPR correction |
| ASS1 | Citrullinemia type I; cancer metabolic reprogramming | Ass1 knockout cell lines; xenograft models for tumor growth |
| ASL | Argininosuccinic aciduria; TCA cycle crosstalk | Asl knockout mice; hepatocyte-specific knockout |
| ARG1 | Hyperargininemia; cancer immune evasion | Arg1 conditional knockout; syngeneic tumor models |
| CPS1 | CPS1 deficiency; hyperammonemia | Cps1 knockout mice; liver-specific rescue models |
Inherited Urea Cycle Disorders
Mutations in CPS1, OTC, ASS1, ASL, ARG1, or NAGS cause inherited urea cycle disorders, leading to hyperammonemia, encephalopathy, and early death if untreated. OTC deficiency is the most common, followed by ASS1 deficiency (citrullinemia type I) and ASL deficiency (argininosuccinic aciduria). Newborn screening and dietary management with nitrogen-scavenging drugs are standard, but curative options remain limited.
Cancer Metabolism and Immune Evasion
Urea cycle dysregulation is increasingly recognized in cancer. Many tumors downregulate ASS1 and other urea cycle enzymes, diverting aspartate to pyrimidine synthesis and altering arginine availability. This reprogramming supports proliferation, redox balance, and immune evasion by limiting arginine for T cells. Targeting urea cycle enzymes, such as ARG1 or ASS1, is being explored as a therapeutic strategy.
Alzheimer's Disease and Neurodegeneration
In Alzheimer's disease, amyloid-beta induces ammonia production in astrocytes, which activates an astrocytic urea cycle to detoxify ammonia. This compensatory pathway, however, may impair memory by altering neurotransmitter balance and energy metabolism. The urea cycle thus represents a novel link between protein aggregation and cognitive decline.
Other Metabolic and Neurological Conditions
Urea cycle dysfunction has been linked to hepatic encephalopathy, Reye syndrome, and mitochondrial disorders. In addition, arginine depletion via arginase activity contributes to immune suppression in the tumor microenvironment, highlighting the broad impact of this pathway.
From urea cycle-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of OTC cause hyperammonemia? | OTC knockout (KO) mouse or cell line |
| Does a specific point mutation in ASS1 impair enzyme activity? | ASS1 point-mutation knock-in via CRISPR |
| Can wild-type CPS1 rescue urea cycle function? | CPS1 knock-in or overexpression in KO background |
| How does ARG1 tagging affect subcellular localization? | Tagged knock-in of ARG1 (e.g., GFP) in hepatocytes |
| Does overexpression of ASL enhance ureagenesis? | ASL overexpression in liver cell lines |
| Can CRISPR screening identify modifiers of urea cycle flux? | Genome-wide CRISPR knockout library in metabolic cell models |
How to Study the urea cycle Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression levels | Quantify urea cycle enzyme transcripts in tissues or cells |
| 15N metabolic tracing | Flux through urea cycle | Measure ureagenesis and nitrogen disposal |
| Enzyme activity assay | Catalytic activity of CPS1, OTC, ASS1, ASL, ARG1 | Diagnose urea cycle disorders and validate models |
| Western blot | Protein abundance and modifications | Assess enzyme expression in KO or overexpression models |
| CRISPR knockout screen | Gene essentiality and fitness | Identify modifiers of urea cycle dependency in cancer |
| Immunofluorescence | Subcellular localization | Determine mitochondrial vs cytosolic distribution of enzymes |
| Mass spectrometry | Metabolite levels (urea, arginine, citrulline) | Quantify pathway intermediates in disease models |
Genomic and Transcriptomic Profiling
RNA-seq and targeted sequencing can quantify expression of urea cycle genes and identify mutations in patient samples. Single-cell RNA-seq reveals cell-type-specific expression, such as astrocytic urea cycle genes in Alzheimer's disease.
Metabolic Flux Analysis
Stable isotope tracing with 15N-labeled ammonia or 13C-labeled substrates coupled to mass spectrometry measures urea cycle flux and its crosstalk with the TCA cycle. This approach is critical for understanding how cancer cells reprogram nitrogen metabolism.
Proteomics and Enzyme Activity Assays
Western blotting and activity assays for CPS1, OTC, ASS1, ASL, and ARG1 provide direct functional readouts. Proteomics can quantify post-translational modifications and protein interactions.
CRISPR-Based Functional Genomics
CRISPR knockout, activation, and interference screens enable systematic dissection of urea cycle gene function in metabolic and disease contexts. Pooled screens with metabolite-based selection can identify synthetic lethal interactions.
How CRISPR Can Be Used to Study GO:0000050 urea cycle
Knockout
CRISPR knockout of urea cycle genes (e.g., OTC, ASS1, ARG1) in cell lines and mice recapitulates key features of urea cycle disorders and cancer metabolic reprogramming. These models are used to test metabolic dependencies and rescue strategies.
Point Mutation
Point mutations identified in patients (e.g., ASS1 mutations) can be introduced via CRISPR base editing or homology-directed repair to study enzyme kinetics and disease severity. Such models help distinguish pathogenic from benign variants.
Knock-in
Knock-in of tagged versions (e.g., GFP-ARG1) or wild-type cDNA into endogenous loci allows real-time tracking of enzyme localization and dynamics. Knock-in of human disease alleles into mouse models enables in vivo studies.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of urea cycle enzymes (e.g., ASL, CPS1) can enhance ureagenesis and rescue hyperammonemia in disease models. Overexpression in cancer cells helps define oncogenic roles.
How EDITGENE Supports urea cycle Research
Researchers studying urea cycle-related genes often need to determine whether a candidate gene is causally involved in metabolic dysfunction, cancer progression, or neurodegeneration. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell and animal models, enabling rigorous functional validation of urea cycle targets.
Contact EDITGENE today to design your custom CRISPR model for urea cycle research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CPS1 Knockout HEK293 Cell Line | EDJ-KQ1984 | Human | 1373 | Details Get a Quote |
| SIRT5 Knockout HEK293 Cell Line | EDC07605 | Human | 23408 | Details Get a Quote |
| ARG2 Knockout HEK293 Cell Line | EDC09599 | Human | 384 | Details Get a Quote |
| ASL Knockout HEK293 Cell Line | EDJ-KQ3432 | Human | 435 | Details Get a Quote |
| ARG1 Knockout HEK293 Cell Line | EDJ-KQ4083 | Human | 383 | Details Get a Quote |
| ASS1 Knockout HEK293 Cell Line | EDJ-KQ4105 | Human | 445 | Details Get a Quote |
| OTC Knockout HEK293 Cell Line | EDJ-KQ5388 | Human | 5009 | Details Get a Quote |
| SLC25A15 Knockout HEK293 Cell Line | EDJ-KQ6929 | Human | 10166 | Details Get a Quote |
| SLC25A2 Knockout HEK293 Cell Line | EDJ-KQ9922 | Human | 83884 | Details Get a Quote |
| AGMAT Knockout HEK293 Cell Line | EDJ-KQ12309 | Human | 79814 | Details Get a Quote |
| NR1H4 Knockout HEK293 Cell Line | EDJ-KQ13735 | Human | 9971 | Details Get a Quote |
| NAGS Knockout HEK293 Cell Line | EDJ-KQ14366 | Human | 162417 | Details Get a Quote |
| CPS1 Knockout A-549 Cell Line | EDJ-KQ21962 | Human | 1373 | Details Get a Quote |
| CPS1 Knockout HCT 116 Cell Line | EDJ-KQ21963 | Human | 1373 | Details Get a Quote |
| CPS1 Knockout HeLa Cell Line | EDJ-KQ21964 | Human | 1373 | Details Get a Quote |
Displaying Records 1 To 15 Of 56 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About urea cycle
What is the urea cycle?
The urea cycle (GO:0000050) is a metabolic pathway that converts toxic ammonia into urea for excretion, while also producing arginine.
What genes are involved in the urea cycle?
Core genes include CPS1, OTC, ASS1, ASL, ARG1, and NAGS, along with transporters like SLC25A15 and SLC25A13.
What diseases are associated with urea cycle defects?
Inherited urea cycle disorders cause hyperammonemia and neurological damage; acquired dysregulation is linked to cancer and Alzheimer's disease.
How is the urea cycle regulated?
It is regulated by N-acetylglutamate, hormonal signals (glucagon, insulin), and transcriptional control of enzyme genes.
What is the role of the urea cycle in cancer?
Cancer cells reprogram the urea cycle to support pyrimidine synthesis, redox balance, and immune evasion.
How does the urea cycle relate to Alzheimer's disease?
Astrocytic urea cycle activity detoxifies amyloid-beta-derived ammonia but may impair memory.
What methods are used to study the urea cycle?
Common methods include RNA-seq, metabolic flux analysis, enzyme activity assays, and CRISPR screens.
Can CRISPR be used to model urea cycle disorders?
Yes, CRISPR knockout, point mutation, and knock-in models recapitulate disease features and enable therapeutic testing.
What is the rate-limiting enzyme of the urea cycle?
CPS1 is the rate-limiting enzyme, activated by N-acetylglutamate.
Where does the urea cycle occur in the cell?
The cycle spans mitochondria and cytosol, with CPS1 and OTC in mitochondria and ASS1, ASL, and ARG1 in the cytosol.
Conclusion
The urea cycle (GO:0000050) is a fundamental metabolic pathway with critical roles in nitrogen detoxification, arginine synthesis, and disease. Its dysregulation contributes to inherited disorders, cancer progression, and neurodegeneration, making it a compelling target for basic and translational research. Advances in CRISPR technology now allow precise modeling of urea cycle gene function, offering new opportunities for therapeutic discovery.
References
- 1. Morris SM Jr. 2002. Regulation of enzymes of the urea cycle and arginine metabolism.. Annu Rev Nutr 22:87-105 PMID: 12055339
- 2. Ju YH et al.. 2022. Astrocytic urea cycle detoxifies Aβ-derived ammonia while impairing memory in Alzheimer's disease.. Cell Metab 34(8):1104-1120.e8 PMID: 35738259
- 3. Burton BK. 2000. Urea cycle disorders.. Clin Liver Dis 4(4):815-30, vi PMID: 11232359
- 4. Zhang Y et al.. 2024. Hierarchical tricarboxylic acid cycle regulation by hepatocyte arginase 2 links the urea cycle to oxidative metabolism.. Cell Metab 36(9):2069-2085.e8 PMID: 39116884
- 5. Ghosh N et al.. 2024. Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes.. Biochem Pharmacol 228:116326 PMID: 38815626
- 6. Shou Y et al.. 2025. Urea cycle dysregulation: a new frontier in cancer metabolism and immune evasion.. Cell Commun Signal 23(1):307 PMID: 40598601
- 7. Zhou J et al.. 2025. The emerging roles of the urea cycle in tumor microenvironment and therapies.. Trends Cancer 11(12):1203-1219 PMID: 40946047
- 8. Al-Thani NA et al.. 2025. The Role of the Urea Cycle in the Alzheimer's Disease Brain.. J Neurochem 169(3):e70033 PMID: 40022483
